Citywire news

Uncertainty over the government's levy on oil and gas companies provided a buying opportunity for our columnist in one leading renewables fund, but left him wondering where the government is going in its clean energy policy.

A flood of private equity cash helps TR Property to eleventh consecutive year of outperformance with a 21.4% total investment return in year to 31 March, but the shares slip to an 'unwarranted' 11% discount.

After a record rebound from the pandemic, the last 12 months have been difficult for Fidelity China Special Situations but fund manager Dale Nicholls is confident the easing of lockdowns will enable small and mid-cap portfolio to thrive.

UK shares start the week strongly as traders return from the long bank holiday, with a jump in the oil price pushing commodity stocks higher. China investment trusts extend their rally.

Proton beam cancer treatment provider, once one of fund manager Neil Woodford’s bright hopes, falls into administration, knocking a hole in Schroder UK Public Private whose managers criticise the group's 'flawed' strategy.

‘We believe the unprecedented sell-off in emerging biotech has driven valuations to 20-year lows, giving a compelling valuation argument to our bullish stance on the sector,’ says fund manager Geoff Hsu.

Fund manager of Impax Environmental Markets sees its shares tumble 12% after revealing a sharp slowdown in its six month fund inflows.

The £2bn Worldwide Healthcare trust has fallen foul of the bear market in biotechnology but its managers believe renewed bids and mergers will provide a sector rallying point.

A valuation tool developed by star fund manager Terry Smith shows UK ‘micro-cap’ stocks trading at their biggest discount to fair value in 20 years, according to Stuart Widdowson of Odyssean investment trust.

A sharp fall in the crude prices leaves FTSE 100 struggling for direction as energy and commodity stocks take a hit, while Dr Martens is one bright spot, jumping 25% after bumper results.